A team of researchers from Intellia Therapeutics, Inc. and Regeneron Pharmaceuticals has conducted the first clinical trial involving in vivo CRISPR human gene editing. In their paper published in The New England Journal ...
Karin Hellgren and colleagues examined pregnancy outcomes in relation to disease activity and antirheumatic treatment strategies in women with rheumatoid arthritis (RA). This matched cohort study from Sweden and Denmark explored ...
Jun 18, 2021
0
1
Cancer cells can develop resistance to therapy through both genetic and non-genetic mechanisms. But it is unclear how and why one of these routes to resistance prevails. Understanding this 'choice' by the cancer cells may ...
Jun 17, 2021
0
5
Researchers have developed a new approach to gene therapy that leans on the common pain reliever acetaminophen to force a variety of genetic diseases into remission.
Jun 14, 2021
0
36
For over a century, researchers have known about "the bends", a serious condition affecting scuba divers. However, we still know relatively little about its physiological basis. Doctors do not yet have a definitive test for ...
Jun 10, 2021
0
10
Genetic information stored in biobanks brings new opportunities for individualized health care. According to a new study by VTT, tailoring based on genetic information can improve treatment outcomes of blood thinner treatment. ...
Jun 8, 2021
0
0
Doctors for the first time have used a form of gene therapy to restore partial vision in a blind person, according to findings announced Monday.
May 24, 2021
0
575
More than two-thirds of pancreatic cancer patients harboring genetic mutations saw their tumor stop growing or shrink substantially after being switched from intensive chemotherapy to the PARP inhibitor rucaparib as a maintenance ...
May 10, 2021
0
21
A gene therapy protects eye cells in mice with a rare disorder that causes vision loss, especially when used in combination with other gene therapies, shows a study published today in eLife.
Apr 13, 2021
0
5
Various genetic alterations in circulating tumor cells (CTCs) were associated with clinical outcomes and resistance to hormone therapy in patients with metastatic castrate-resistant prostate cancer (mCRPC), according to results ...
Mar 26, 2021
0
2
